Nu-Med Plus (NUMD) Debt to Equity (2017 - 2021)
Nu-Med Plus' Debt to Equity history spans 8 years, with the latest figure at $0.05 for Q1 2021.
- On a quarterly basis, Debt to Equity rose 115.27% to $0.05 in Q1 2021 year-over-year; TTM through Mar 2021 was $0.05, a 115.27% increase, with the full-year FY2020 number at $0.02, up 106.51% from a year prior.
- Debt to Equity hit $0.05 in Q1 2021 for Nu-Med Plus, up from $0.02 in the prior quarter.
- Over the last five years, Debt to Equity for NUMD hit a ceiling of $0.57 in Q3 2020 and a floor of -$0.85 in Q1 2018.
- Historically, Debt to Equity has averaged -$0.01 across 5 years, with a median of $0.01 in 2020.
- The widest YoY moves for Debt to Equity: up 5945.11% in 2020, down 759.29% in 2020.
- Tracing NUMD's Debt to Equity over 5 years: stood at $0.29 in 2017, then soared by 54.38% to $0.45 in 2018, then tumbled by 168.27% to -$0.31 in 2019, then surged by 106.51% to $0.02 in 2020, then skyrocketed by 144.93% to $0.05 in 2021.
- Business Quant data shows Debt to Equity for NUMD at $0.05 in Q1 2021, $0.02 in Q4 2020, and $0.57 in Q3 2020.